XOMETRY INC-A (XMTR) Fundamental Analysis & Valuation

NASDAQ:XMTR • US98423F1093

Current stock price

49.77 USD
+0.37 (+0.75%)
At close:
49.77 USD
0 (0%)
After Hours:

This XMTR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. XMTR Profitability Analysis

1.1 Basic Checks

  • XMTR had positive earnings in the past year.
  • XMTR had a positive operating cash flow in the past year.
  • XMTR had negative earnings in each of the past 5 years.
  • XMTR had negative operating cash flow in 4 of the past 5 years.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.77%, XMTR is doing worse than 84.78% of the companies in the same industry.
  • The Return On Equity of XMTR (-22.40%) is worse than 80.43% of its industry peers.
Industry RankSector Rank
ROA -8.77%
ROE -22.4%
ROIC N/A
ROA(3y)-8.57%
ROA(5y)-9.65%
ROE(3y)-19.64%
ROE(5y)-18.75%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • XMTR's Gross Margin of 39.14% is fine compared to the rest of the industry. XMTR outperforms 78.26% of its industry peers.
  • In the last couple of years the Gross Margin of XMTR has grown nicely.
  • XMTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y10.7%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XMTR Health Analysis

2.1 Basic Checks

  • XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, XMTR has more shares outstanding
  • The number of shares outstanding for XMTR has been increased compared to 5 years ago.
  • The debt/assets ratio for XMTR is higher compared to a year ago.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • XMTR has an Altman-Z score of 3.94. This indicates that XMTR is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.94, XMTR is doing good in the industry, outperforming 65.22% of the companies in the same industry.
  • XMTR has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.
  • XMTR has a Debt to Equity ratio of 1.19. This is in the lower half of the industry: XMTR underperforms 71.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Altman-Z 3.94
ROIC/WACCN/A
WACC8.9%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.76 indicates that XMTR has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.76, XMTR belongs to the best of the industry, outperforming 89.13% of the companies in the same industry.
  • A Quick Ratio of 3.72 indicates that XMTR has no problem at all paying its short term obligations.
  • XMTR has a Quick ratio of 3.72. This is amongst the best in the industry. XMTR outperforms 95.65% of its industry peers.
Industry RankSector Rank
Current Ratio 3.76
Quick Ratio 3.72
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. XMTR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 860.00% over the past year.
  • XMTR shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.86%.
  • The Revenue has been growing by 37.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)860%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)25.86%
Revenue growth 3Y21.68%
Revenue growth 5Y37.17%
Sales Q2Q%29.52%

3.2 Future

  • The Earnings Per Share is expected to grow by 61.46% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, XMTR will show a quite strong growth in Revenue. The Revenue will grow by 18.48% on average per year.
EPS Next Y93.53%
EPS Next 2Y81.03%
EPS Next 3Y61.46%
EPS Next 5YN/A
Revenue Next Year22.94%
Revenue Next 2Y20.64%
Revenue Next 3Y19.01%
Revenue Next 5Y18.48%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. XMTR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 130.97 indicates a quite expensive valuation of XMTR.
  • Based on the Price/Earnings ratio, XMTR is valued a bit more expensive than the industry average as 69.57% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 27.95, XMTR is valued quite expensively.
  • The Price/Forward Earnings ratio is 67.68, which means the current valuation is very expensive for XMTR.
  • Based on the Price/Forward Earnings ratio, XMTR is valued a bit more expensive than the industry average as 65.22% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of XMTR to the average of the S&P500 Index (38.68), we can say XMTR is valued expensively.
Industry RankSector Rank
PE 130.97
Fwd PE 67.68
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as XMTR's earnings are expected to grow with 61.46% in the coming years.
PEG (NY)1.4
PEG (5Y)N/A
EPS Next 2Y81.03%
EPS Next 3Y61.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XMTR Dividend Analysis

5.1 Amount

  • XMTR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XMTR Fundamentals: All Metrics, Ratios and Statistics

XOMETRY INC-A

NASDAQ:XMTR (4/20/2026, 8:00:02 PM)

After market: 49.77 0 (0%)

49.77

+0.37 (+0.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)05-13
Inst Owners100.6%
Inst Owner Change0.11%
Ins Owners6.06%
Ins Owner Change8.52%
Market Cap2.58B
Revenue(TTM)686.63M
Net Income(TTM)-61.74M
Analysts80
Price Target63.58 (27.75%)
Short Float %10.58%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.51%
Min EPS beat(2)4.7%
Max EPS beat(2)42.32%
EPS beat(4)4
Avg EPS beat(4)171.3%
Min EPS beat(4)4.7%
Max EPS beat(4)541.62%
EPS beat(8)8
Avg EPS beat(8)134.34%
EPS beat(12)12
Avg EPS beat(12)99.08%
EPS beat(16)15
Avg EPS beat(16)79.79%
Revenue beat(2)2
Avg Revenue beat(2)4.14%
Min Revenue beat(2)3%
Max Revenue beat(2)5.29%
Revenue beat(4)3
Avg Revenue beat(4)2.5%
Min Revenue beat(4)-0.07%
Max Revenue beat(4)5.29%
Revenue beat(8)6
Avg Revenue beat(8)1.48%
Revenue beat(12)7
Avg Revenue beat(12)0.68%
Revenue beat(16)9
Avg Revenue beat(16)-0.02%
PT rev (1m)-4.75%
PT rev (3m)-4.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.26%
Valuation
Industry RankSector Rank
PE 130.97
Fwd PE 67.68
P/S 3.76
P/FCF N/A
P/OCF 423.77
P/B 9.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.38
EY0.76%
EPS(NY)0.74
Fwd EY1.48%
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)0.12
OCFY0.24%
SpS13.25
BVpS5.32
TBVpS-0.32
PEG (NY)1.4
PEG (5Y)N/A
Graham Number6.74334 (-86.45%)
Profitability
Industry RankSector Rank
ROA -8.77%
ROE -22.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.14%
FCFM N/A
ROA(3y)-8.57%
ROA(5y)-9.65%
ROE(3y)-19.64%
ROE(5y)-18.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y10.7%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 160.96%
Cap/Sales 4.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.76
Quick Ratio 3.72
Altman-Z 3.94
F-Score4
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)157.4%
Cap/Depr(5y)164.13%
Cap/Sales(3y)3.9%
Cap/Sales(5y)3.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)860%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y93.53%
EPS Next 2Y81.03%
EPS Next 3Y61.46%
EPS Next 5YN/A
Revenue 1Y (TTM)25.86%
Revenue growth 3Y21.68%
Revenue growth 5Y37.17%
Sales Q2Q%29.52%
Revenue Next Year22.94%
Revenue Next 2Y20.64%
Revenue Next 3Y19.01%
Revenue Next 5Y18.48%
EBIT growth 1Y21.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year478.31%
EBIT Next 3Y141.37%
EBIT Next 5Y95.44%
FCF growth 1Y28.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y139.56%
OCF growth 3YN/A
OCF growth 5YN/A

XOMETRY INC-A / XMTR Fundamental Analysis FAQ

What is the fundamental rating for XMTR stock?

ChartMill assigns a fundamental rating of 4 / 10 to XMTR.


Can you provide the valuation status for XOMETRY INC-A?

ChartMill assigns a valuation rating of 1 / 10 to XOMETRY INC-A (XMTR). This can be considered as Overvalued.


What is the profitability of XMTR stock?

XOMETRY INC-A (XMTR) has a profitability rating of 2 / 10.


What is the financial health of XOMETRY INC-A (XMTR) stock?

The financial health rating of XOMETRY INC-A (XMTR) is 5 / 10.